logo
  

Sempra Energy : Jessie Knight, EVP Of External Affairs, Plans To Retire Nov. 1

Sempra Energy (SRE) announced that Jessie J. Knight, Jr., executive vice president of external affairs for Sempra Energy and chairman of Southern California Gas Co. and San Diego Gas & Electric or SDG&E, plans to retire November 1.

Steven Davis, currently president and chief operating officer of SDG&E, has been elected to succeed Knight as executive vice president of external affairs and corporate strategy for Sempra Energy, effective September 26.

In his new role, Davis, 59, will report directly to Debra L. Reed, chairman and CEO of Sempra Energy, and oversee all of Sempra Energy's communications, government relations, regulatory and international affairs activities, as well as corporate social responsibility and long-term strategy review. Once Davis' new appointment is effective, Knight, 64, will continue on as a Sempra Energy executive vice president and chairman of the two California utilities until his retirement.

Davis has served as president and chief operating officer of SDG&E since January 2014. Previously, from 2012 to 2014, he was Sempra Energy's senior vice president of external affairs. Prior to that, he was Sempra Energy's vice president of investor relations and corporate communications and, from 2006 to 2010, Sempra Energy's vice president of communications and community partnerships.

Previously, Davis served as senior vice president of external relations and chief financial officer for SDG&E and SoCalGas from 2004 to 2006. Prior to that, he was senior vice president of customer service and external relations for SDG&E and SoCalGas and vice president of distribution operations for SDG&E.

Davis first joined SDG&E in 1980 as an associate accountant and then served in a series of increasingly responsible positions in accounting and regulatory, governmental, community and environmental affairs.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT